Skip to main content
. 2017 Mar 7;19(4):271–278. doi: 10.1016/j.neo.2017.01.008

Figure 2.

Figure 2

Evaluation of NIC in serum from two study cohorts. (A) Proteogenex samples; (B) Asterand samples. Box and whiskers show data from minimum to maximum. Data were compared by one-way ANOVA adjusted for multiple comparisons. Values below the LLOQ were assigned the LLOQ (n = 1, breast cancer, B). *P < .05, **P < .01, ***P < .001.